Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Drug Policies .

Tecelra® (afamitresgene autoleucel)

Niktimvo™ (axatilimab-csfr)

Actemra, Tofidence, Tyenne

Acthar Gel, Cortrophin Gel

Aloxi

Benlysta

Berinert

Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive

Cerezyme® (imiglucerase)

Aralast NP; Glassia; Prolastin-C; Zemaira

Hizentra, Gammagard Liquid, Gamunex-C, Gammaked, Hyqvia, Cuvitri, Cutaquig, Xembify

Durolane, Euflexxa, Gel-One, GelSyn-3, GenVisc 850, Hyalgan, Hymovis, Monovisc, Orthovisc, Supartz/Supartz FX, Synojoynt, Synvisc, Synvisc-One, TriVisc, VISCO-3, Triluron, sodium hyaluronate 1%

Lucentis, Byooviz, Cimerli

Orencia

Elelyso

Rituxan, Truxima, Ruxience, Riabni

Sandostatin LAR

Soliris, Bkemv, Epysqli

Stelara, Wezlana, Selarsdi, Pyzchiva

Synagis® (Palivizumab)